TTM
$4.26
YoY change
+10.9%
5Y CAGR
+20.0%
Peak year (2025)
$3.59
Latest annual
$3.59
EPS (Diluted) history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: $3.59
EPS (Diluted) growth chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: +10.9%
EPS (Diluted) history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | $3.59 | +10.9% | +$0.35 | ||
| 2024 | $3.24 | +20.4% | +$0.55 | ||
| 2023 | $2.69 | +60.1% | +$1.01 | ||
| 2022 | $1.68 | +5.3% | +$0.08 | ||
| 2021 | $1.59 | +10.4% | +$0.15 | ||
| 2020 | $1.44 | +19.0% | +$0.23 | ||
| 2019 | $1.21 | -0.4% | −$0.00 | ||
| 2018 | $1.22 | +0.0% | +$0.00 | ||
| 2017 | $1.22 | +12.4% | +$0.13 | ||
| 2016 | $1.08 | +9.2% | +$0.09 | ||
| 2015 | $0.99 | +17.3% | +$0.15 | ||
| 2014 | $0.85 | -1.0% | −$0.01 | ||
| 2013 | $0.85 | +26.2% | +$0.18 | ||
| 2012 | $0.68 | +24.6% | +$0.13 | ||
| 2011 | $0.54 | +21.2% | +$0.10 | ||
| 2010 | $0.45 | +26.9% | +$0.09 | ||
| 2009 | $0.35 | +28.6% | +$0.08 | ||
| 2008 | $0.27 | +5.5% | +$0.01 | ||
| 2007 | $0.26 | +50.5% | +$0.09 | ||
| 2006 | $0.17 | +21.9% | +$0.03 | ||
| 2005 | $0.14 | +9.7% | +$0.01 | ||
| 2004 | $0.13 | +10.0% | +$0.01 | ||
| 2003 | $0.12 | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — | ||
| 1989 | — | — | — | ||
| 1988 | — | — | — | ||
| 1987 | — | — | — | ||
| 1986 | — | — | — | ||
| 1985 | — | — | — |
- 2025$3.59+10.9%
- 2024$3.24+20.4%
- 2023$2.69+60.1%
- 2022$1.68+5.3%
- 2021$1.59+10.4%
- 2020$1.44+19.0%
- 2019$1.21-0.4%
- 2018$1.22+0.0%
- 2017$1.22+12.4%
- 2016$1.08+9.2%
- 2015$0.99+17.3%
- 2014$0.85-1.0%
- 2013$0.85+26.2%
- 2012$0.68+24.6%
- 2011$0.54+21.2%
- 2010$0.45+26.9%
- 2009$0.35+28.6%
- 2008$0.27+5.5%
- 2007$0.26+50.5%
- 2006$0.17+21.9%
- 2005$0.14+9.7%
- 2004$0.13+10.0%
- 2003$0.12—
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
- 1989——
- 1988——
- 1987——
- 1986——
- 1985——
EPS (Diluted) values are taken from Novo Nordisk's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About EPS (Diluted) at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current diluted EPS (TTM) is $4.26. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Novo Nordisk (NVO) diluted EPS is 23.03 DKK – edged up 1.8% year-over-year.
Novo Nordisk diluted EPS has grown for 31 consecutive years, with a +20.6% compound annual growth rate over 2020–2025 (5 years).
23.03 DKK stands as the all-time-high annual diluted EPS, posted in 2025, against a low of 0.09 DKK during 1989.
Novo Nordisk EPS (Diluted) by Year
Novo Nordisk EPS (Diluted) 2025: $3.59
In 2025, Novo Nordisk reported diluted EPS of 23.03 DKK ($3.59), edged up 1.8% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk EPS (Diluted) 2024: $3.24
Novo Nordisk diluted EPS in 2024 was 22.63 DKK ($3.24), grew 21.5% from 2023.
Novo Nordisk EPS (Diluted) 2023: $2.69
2023's diluted EPS for Novo Nordisk came in at 18.62 DKK ($2.69), surged 52.4% from 2022.
Novo Nordisk EPS (Diluted) 2022: $1.68
Novo Nordisk posted diluted EPS of 12.22 DKK ($1.68) in 2022, grew 17.8% from 2021.
Novo Nordisk EPS (Diluted) 2021: $1.59
Novo Nordisk diluted EPS in 2021 was 10.37 DKK ($1.59).
See more financial history for Novo Nordisk (NVO). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Novo Nordisk (NVO), ranked by their latest diluted EPS
| $22.95 | |
| $17.74 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $2.37
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation